NasdaqGS:RPRXPharmaceuticals
How Royalty Pharma’s New AI and Dealmaking Hires Could Shape RPRX’s Royalty Sourcing Strategy
Royalty Pharma has recently strengthened its leadership bench, appointing former IQVIA technology leader Lucas Glass as Head of Artificial Intelligence and bringing in Greg Butz from Bank of America as Executive Vice President, Partnering & Investments, alongside elevating Chris Hite to Chairman, Partnering & Investments and expanding its regional leadership with a new Head of Asia.
These hires point to a company-wide push to embed artificial intelligence into decision-making and broaden...